StockData
Genmab A/S logo

Genmab A/S (GMAB) income statement

GMABNasdaqPharmaceutical PreparationsAlso trades as GNMSF
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Score 0/30
$50.97−0.99 (-1.91%)

Close on Nov 18, 2026

Genmab A/S income statement

Ratios

Latest available, balances at Dec 31, 2025

Profitability, FY

Gross margin
–
Operating margin
–
Net margin
–
Return on equity, FY2025
–

Financial strength

Current ratio
–
Debt to equity
–
Debt to assets
–
Cash to current liabilities
–

Valuation

P/E ratio
–
Price to sales
–
Price to book
–
Dividend yield
–

Valuation ratios need the share price and fill in once daily prices are connected.

See a number that looks wrong?